MyAverix Finance
F · Healthcare
ARMATA PHARMACEUT. (TG1N)
Biotechnology
ARMATA PHARMACEUT. (TG1N) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-31, reported market cap is $250.93M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TG1N
ARMATA PHARMACEUT. (TG1N) — FAQ
What is ARMATA PHARMACEUT.'s market cap?
ARMATA PHARMACEUT. (TG1N) has a reported market cap of $250.93M (data as of 2026-03-31).
What is TG1N's P/E ratio?
The price-to-earnings (P/E) ratio for ARMATA PHARMACEUT. (TG1N) is 18.00 (data as of 2026-03-31).
Does ARMATA PHARMACEUT. pay a dividend?
Dividend yield is not available in the current snapshot for ARMATA PHARMACEUT. (TG1N). Check the MyAverix Finance app for the latest dividend data.
What sector is ARMATA PHARMACEUT. in?
ARMATA PHARMACEUT. (TG1N) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TG1N listed on?
TG1N is listed on F.
What is ARMATA PHARMACEUT.'s net margin?
ARMATA PHARMACEUT. (TG1N) reports a net margin of 0.0% (data as of 2026-03-31).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.